Bigbang Pharma Private Limited
About Bigbang Pharma Private Limited
Data last updated:
Bigbang Pharma Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 20 March 2015.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2015PTC154416. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anand Naganath Sarade and Satish Vasant Mandeve.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Bhor Complex Pune – Solapur Road Urali Kanchan Nr Motor Stand Tal – Haveli, Maharashtra, India – 412202.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.2 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net loss of ₹4,565 (net margin -1.4%) and EBITDA of -₹1,280 (EBITDA margin -0.4%).
Company details
Contact details
Bigbang Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBhor Complex Pune – Solapur Road Urali Kanchan Nr Motor Stand Tal – Haveli, Maharashtra, India – 412202
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Bigbang Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bigbang Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bigbang Pharma Private Limited, buy the company report.
Financials of Bigbang Pharma Private Limited
FY 2017 filings availableBigbang Pharma Private Limited reported revenue of ₹3.2 Lakh (up 37% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 37% in the latest year. EBITDA rose 98% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹3.2 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1,280 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4,565 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.4% | ||
| Net Profit Margin | -1.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Bigbang Pharma Private Limited, buy the company report.
Board of directors of Bigbang Pharma Private Limited
Bigbang Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Naganath Sarade | Director | 20 Mar 2015 | 11 Years 7 Months | As last reported |
| Satish Vasant Mandeve | Director | 20 Mar 2015 | 11 Years 7 Months | As last reported |
Peer comparison
Bigbang Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fasih Industries Private Limited | ₹3.23 Lakh (FY 2023) | 47.0% | Mumbai, Maharashtra, India | |||
| Glowsol Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2021) | -19.0% | Mumbai, Maharashtra, India | |||
| Cureit Pest Management Private Limited | ₹3.22 Lakh (FY 2017) | Kolkata, West Bengal, India | ||||
| Protagon Bio-Chem Private Limited | ₹3.21 Lakh (FY 2024) | 5.0% | Agra, Uttar Pradesh, India | |||
| Vaj-Ayur Wellnness Private Limited | ₹3.2 Lakh (FY 2024) | 1902.0% | Thiruvananthapuram, Kerala, India | |||
| Bigbang Pharma Private Limitedthis company | ₹3.2 Lakh (FY 2017) | -₹4,565 | -1.4% | 37.0% | Pune, Maharashtra, India | |
| Hardsol Chemicals Pvt.Ltd. | ₹3.2 Lakh (FY 2025) | -92.0% | Kolkata, West Bengal, India | |||
| Maytas Pharma Private Limited | ₹3.19 Lakh (FY 2021) | Indore, Madhya Pradesh, India | ||||
| Choudhary Pharma Private Limited | ₹3.19 Lakh (FY 2025) | -9.0% | Pandaul, Bihar, India | |||
| Anandisha Enterprise Private Limited | ₹3.19 Lakh (FY 2024) | 0.0% | Ahmedabad, Gujarat, India | |||
| Aarway Healthcare Private Limited | ₹3.19 Lakh (FY 2025) | 495.0% | Delhi, India |
To see the full peer comparison of Bigbang Pharma Private Limited, buy the company report.
Auditor
Bigbang Pharma Private Limited is audited by A.B.BHALERAO & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.B.BHALERAO & CO. | FY 2017 | 135006W |
Shareholding
The shareholding of Bigbang Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Bigbang Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bigbang Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bigbang Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bigbang Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bigbang Pharma Private Limited, buy the company report.
Recent activity
Bigbang Pharma Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Anand Naganath Sarade was appointed as Director on 20 Mar 2015.
Frequently asked questions
Bigbang Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bigbang Pharma was a private limited company based in Pune, Maharashtra, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 20 March 2015 and is registered under CIN U74900PN2015PTC154416. The company has been struck off by the Registrar of Companies and is no longer operational.
Bigbang Pharma had 2 directors:
- Anand Naganath Sarade - Director
- Satish Vasant Mandeve - Director
The CIN (Corporate Identification Number) of Bigbang Pharma is U74900PN2015PTC154416. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bigbang Pharma is at Bhor Complex Pune – Solapur Road Urali Kanchan Nr Motor Stand Tal – Haveli, Maharashtra, India – 412202.
Bigbang Pharma was incorporated on 20 March 2015. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Bigbang Pharma on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
No. Bigbang Pharma has 1 GST registration on record and it is cancelled or inactive.
Bigbang Pharma operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Bigbang Pharma by revenue are Fasih Industries Private Limited, Glowsol Pharmaceuticals Private Limited, Cureit Pest Management Private Limited, Protagon Bio-Chem Private Limited, Vaj-Ayur Wellnness Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anand Naganath Sarade was appointed as Director on 20 Mar 2015. Satish Vasant Mandeve was appointed as Director on 20 Mar 2015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
